Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxingshigan-Yinqiaosan vs Oseltamivir for H1N1 Influenza
NCT00935194Phase 4Completed
- Sponsor
- Capital Medical University
- Start
- Jul 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of yinqiaosan + maxingganshitang in influenza A H1N1 infection (H1N1), sponsored by Capital Medical University. Started Jul 2009; status: completed.
02
Drugs
yinqiaosan + maxingganshitang
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT00935194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00935194.